Stock listing
Aytu Biopharma, Inc.
Selected listing: A3D38R · LS · EUR · DE
Aytu Biopharma, Inc. (Lang & Schwarz: A3D38R), Health Technology. Latest release Sep 22, 2026: Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter…

- Ticker
- Lang & Schwarz: A3D38R
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Aytu Biopharma, Inc.
Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
September 22, 2026
Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026
September 16, 2026
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
May 31, 2026
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
May 18, 2026
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
May 13, 2026
Events
Research Aytu Biopharma, Inc.
Aytu Biopharma, Inc. company profile
View the public company page for Aytu Biopharma, Inc. on 6ix.
Aytu Biopharma, Inc. news
Read company news and market updates connected to Aytu Biopharma, Inc..
Aytu Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Aytu Biopharma, Inc..
Alternate listings
AYTU:NASDAQ
US · USD
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is A3D38R:LS.
AYTU:BOATS
US · USD
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is A3D38R:LS.
AY20:GETTEX
DE · EUR
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is A3D38R:LS.
AY20:MUN
DE · EUR
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is A3D38R:LS.
0A8M:LSE
GB · USD
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is A3D38R:LS.
A3D38R:LSX
DE · EUR
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is A3D38R:LS.